RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Spex Capital
S

Spex Capital portfolio

Spex Capital has 1 portfolio company on record at Recent Funding.

Website: spexcapital.com.
Type: Venture capital.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 0.
Capital in their rounds: $5M.
Latest deal: Skin Analytics · Sep 1, 2020.
About this page

It is a venture capital firm based in London, GB, founded in 2021. Its most recent investment on record is Skin Analytics's $5M Series A round in September 2020, alongside Mustard Seed, RYSE Asset Management, Nesta Impact Investments and 2 others. That company is in Health and bio.

About Spex Capital

Firm type: Venture capital.
Headquarters: London, GB.
Founded: 2021.
Stages: Seed, Series A.
Sectors: Deep Tech, Digital Health, Enterprise Software, Healthtech, Impact & Social Good, Medical Devices, SaaS.
Check size: $550K to $5.5M.
Portfolio companies: 7.
Exits: 0.
Rounds led: 0.

What Spex Capital invests in

How Spex Capital invests

StageDealsCapital in rounds
Series A 1 100%$5M

Spex Capital portfolio companies

CompanyRound with Spex CapitalTotal raisedLatest raise
SSkin Analytics
Health and bio
Series A · $5M$25.29MApr 16, 2025
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 1 round on Recent Funding that name Spex Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Spex Capital, which is a subset of its real portfolio. API: /api/v1/investors/spex-capital (get a free API key). More: the most active VC firms and new venture capital funds.